載入...
P-042. Prospective and Randomized Comparison of Tenofovir and Entecavir in Hepatitis B Reactivation Prophylaxis in Patients Receiving Immunosuppressive Therapy
INTRODUCTION: Current guidelines recommend the use of prophylactic nucleoside(t)ide analogs in the prevention of Hepatitis B virus(HBV) reactivation due to immunosuppressive(IS) treatments. There is no prospective randomized study evaluating the efficacy of tenofovir disoproxil fumarate(TDF) in this...
Na minha lista:
| 發表在: | Turk J Gastroenterol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Turkish Society of Gastroenterology
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7021026/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2019.48 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|